Literature DB >> 11044577

Efficacy of intracochlear administration of betamethasone on peripheral vestibular disorder in the guinea pig.

H Shimogori1, H Yamashita.   

Abstract

We evaluated the effect of steroid hormone on vestibular function in a guinea pig of peripheral vestibular disorder. The right lateral semicircular canal was surgically damaged, and after surgery, animals were treated with 0.1 mg/ml of betamethasone in saline, 1 mg/ml of betamethasone in saline, or saline only, which was administrated directly into the scala tympani by osmotic pump. Rotation tests were performed, and the post-rotatory nystagmus (PRN) ratio (PRN number after counterclockwise rotation/PRN number after clockwise rotation) was calculated. The PRN ratio was recovered to normal at 5 days after treatment in the betamethasone administrated groups, but it did not recover to normal until 14 days after treatment in the saline administrated group. Results indicate that in the vestibular periphery steroid hormones may play an important role in recover of vestibular function.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11044577     DOI: 10.1016/s0304-3940(00)01534-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  Microsystems technologies for drug delivery to the inner ear.

Authors:  Erin E Leary Pararas; David A Borkholder; Jeffrey T Borenstein
Journal:  Adv Drug Deliv Rev       Date:  2012-02-21       Impact factor: 15.470

2.  A nanoliter resolution implantable micropump for murine inner ear drug delivery.

Authors:  Farzad Forouzandeh; Xiaoxia Zhu; Ahmed Alfadhel; Bo Ding; Joseph P Walton; Denis Cormier; Robert D Frisina; David A Borkholder
Journal:  J Control Release       Date:  2019-01-25       Impact factor: 9.776

3.  Effect of transtympanic betamethasone delivery to the inner ear.

Authors:  Halil Erdem Özel; Fatih Özdoğan; Seren Gülşen Gürgen; Erkan Esen; Adin Selçuk; Selahattin Genç
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-29       Impact factor: 2.503

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.